New Glipfield M Tablet
Glimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Angkuk Newpharm Co., Ltd.
MFDS item code 201603557 · Approved 2016.06.17
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist in the blood sugar control of patients with type 2 diabetes by using glimepiride and metformin together. Taking this medication alongside dietary management and exercise can effectively manage blood sugar levels. This helps in the treatment of diabetes and enhances the patient's health management.
This medicine is administered 1~2 times daily immediately before or with a meal. The dose may be adjusted taking into account each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. In general, treatment is initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical studies, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and there has been experience with gradual dose escalation according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional effect with doses above 4mg daily, although some patients have shown better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer according to the dosage regimen of glimepiride and metformin hydrochloride currently being administered concomitantly. Even if a previous dose was missed, do not take more than a single dose at the next administration.
This medication can cause severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued, especially when there is a rapid decline in kidney function or dehydration. It is contraindicated in patients with a renal function of less than 45 mL/min/1.73m², and elderly patients or those in situations where renal function may worsen should have their renal function regularly assessed. The risk of cardiovascular disease may increase during the administration of this medication, so it is essential to thoroughly explain the benefits and risks of treatment to the patient and observe them carefully. It should not be used in patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or breastfeeding women, and patients with severe renal impairment. Patients at high risk for hypoglycemia, such as those with poor nutritional status, irregular eating habits, the elderly, and those with liver dysfunction, require special precautions while taking this medication. In the initial stages of treatment, gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may appear, which are mostly temporary, but if symptoms are severe, consultation with a physician is necessary. Allergic reactions, hematological abnormalities, and symptoms of vitamin B12 deficiency may occur, so regular blood tests and monitoring of vitamin B12 levels are recommended. This medication may interact with other drugs, so patients must inform healthcare professionals of any medications they are taking, particularly medications that may affect renal function. If pregnant or planning to become pregnant, it is safer to switch to insulin therapy instead of using this medication. In cases of overdose, hypoglycemia or lactic acidosis may occur, requiring immediate emergency treatment, and, if necessary, drug removal by hemodialysis may be needed. Care should be taken when driving or operating machinery as hypoglycemia or impaired agility may occur. The safety and efficacy of this medication have not been established in children and adolescents, so it is advisable not to use it in children under 10 years old. During storage, keep it in a tightly sealed container away from the reach of children, and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that prevents air or moisture from entering. Additionally, it is best to store the medication at room temperature, avoiding extremes of heat or cold, specifically between 1°C and 30°C.
White rectangular film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Angkuk Newpharm Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 1mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hawon Pharmaceutical Co., Ltd.
Metformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.